SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Míriam Toledo, Fabio Penna, Francesc Oliva, Melania Luque, Angelica Betancourt, Enrica Marmonti, Francisco J. López-Soriano, Josep M. Argilés, Sílvia Busquets, A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy, Journal of Cachexia, Sarcopenia and Muscle, 2015, 6, 3
  2. 2
    Rose D. Nolen-Walston, Caitlin M. Moore, Ciara A. Barr, Joy E. Tomlinson, Raymond C. Boston, Lawrence R. Soma, Effect of long-term oral administration of a low dosage of clenbuterol on body fat percentage in working and nonworking adult horses, American Journal of Veterinary Research, 2015, 76, 5, 460

    CrossRef

  3. 3
    Míriam Toledo, Jochen Springer, Sílvia Busquets, Anika Tschirner, Francisco J. López-Soriano, Stefan D. Anker, Josep M. Argilés, Formoterol in the treatment of experimental cancer cachexia: effects on heart function, Journal of Cachexia, Sarcopenia and Muscle, 2014, 5, 4
  4. 4
    M. T. Silva, L. A. Wensing, P. C. Brum, N. O. Câmara, E. H. Miyabara, Impaired structural and functional regeneration of skeletal muscles from β2-adrenoceptor knockout mice, Acta Physiologica, 2014, 211, 4
  5. 5
    Shenhav Cohen, James A. Nathan, Alfred L. Goldberg, Muscle wasting in disease: molecular mechanisms and promising therapies, Nature Reviews Drug Discovery, 2014, 14, 1, 58

    CrossRef

  6. 6
    Rashika Joshi, Nijiati Kadeer, Sulaiman Sheriff, Lou Ann Friend, J. Howard James, Ambikaipakan Balasubramaniam, Phosphodiesterase (PDE) inhibitor torbafylline (HWA 448) attenuates burn-induced rat skeletal muscle proteolysis through the PDE4/cAMP/EPAC/PI3K/Akt pathway, Molecular and Cellular Endocrinology, 2014, 393, 1-2, 152

    CrossRef

  7. 7
    Daichi Ijiri, Kanae Ishitani, Saki Shimamoto, Yoshitaka Ishimaru, Akira Ohtsuka, The effects of intraperitoneal clenbuterol injection on protein degradation and myostatin expression differ between the sartorius and pectoral muscles of neonatal chicks, General and Comparative Endocrinology, 2014, 206, 111

    CrossRef

  8. 8
    Marek Sawczuk, Agnieszka Maciejewska-Karlowska, Pawel Cieszczyk, Bogumila Skotarczak, Krzysztof Ficek, Association of theADRB2Gly16Arg and Glu27Gln polymorphisms with athlete status, Journal of Sports Sciences, 2013, 31, 14, 1535

    CrossRef

  9. 9
    Maria Concetta Miniaci, Mariarosaria Bucci, Rita Santamaria, Carlo Irace, Anna Cantalupo, Giuseppe Cirino, Pietro Scotto, CL316,243, a selective β3-adrenoceptor agonist, activates protein translation through mTOR/p70S6K signaling pathway in rat skeletal muscle cells, Pflügers Archiv - European Journal of Physiology, 2013, 465, 4, 509

    CrossRef

  10. 10
    Daichi Ijiri, Kanae Ishitani, Tomoko Matsubara, Miho Hirabayashi, Yukio Kanai, Akira Ohtsuka, In vivo Administration of β2-agonist Clenbuterol and Subsequent Increase in Skeletal Muscle Mass in Neonatal Chicks, The Journal of Poultry Science, 2013, 50, 2, 150

    CrossRef

  11. 11
    Olivier R. Joassard, Anne-Cécile Durieux, Damien G. Freyssenet, β2-Adrenergic agonists and the treatment of skeletal muscle wasting disorders, The International Journal of Biochemistry & Cell Biology, 2013, 45, 10, 2309

    CrossRef

  12. 12
    V. A. Voltarelli, A. V. N. Bacurau, L. R. G. Bechara, C. R. Bueno Júnior, L. H. M. Bozi, K. C. Mattos, V. M. C. Salemi, P. C. Brum, Lack of β2-AR improves exercise capacity and skeletal muscle oxidative phenotype in mice, Scandinavian Journal of Medicine & Science in Sports, 2012, 22, 6
  13. 13
    T. C. Conte, L. H. Silva, M. T. Silva, S. M. Hirabara, A. C. Oliveira, R. Curi, A. S. Moriscot, M. S. Aoki, E. H. Miyabara, The  2-Adrenoceptor Agonist Formoterol Improves Structural and Functional Regenerative Capacity of Skeletal Muscles From Aged Rat at the Early Stages of Postinjury, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2012, 67A, 5, 443

    CrossRef

  14. 14
    Stewart I Head, Tuyen NV Ha, Acute inhibitory effects of clenbuterol on force, Ca2+ transients and action potentials in rat soleus may not involve the β2-adrenoceptor pathway, Clinical and Experimental Pharmacology and Physiology, 2011, 38, 9
  15. 15
    Shogo Sato, Hideki Suzuki, Hisaya Tsujimoto, Ken Shirato, Kaoru Tachiyashiki, Kazuhiko Imaizumi, Casted-immobilization downregulates glucocorticoid receptor expression in rat slow-twitch soleus muscle, Life Sciences, 2011, 89, 25-26, 962

    CrossRef

  16. 16
    Dimitrios D. Nikolopoulos, Chara Spiliopoulou, Stamatios E. Theocharis, Doping and musculoskeletal system: short-term and long-lasting effects of doping agents, Fundamental & Clinical Pharmacology, 2011, 25, 5
  17. 17
    Tatiana L Fonseca, Vanda Jorgetti, Cristiane C Costa, Luciane P Capelo, Ambart E Covarrubias, Ana C Moulatlet, Marilia B Teixeira, Eric Hesse, Priscilla Morethson, Eduardo H Beber, Fatima R Freitas, Charles C Wang, Keico O Nonaka, Ricardo Oliveira, Dulce E Casarini, Telma M Zorn, Patricia C Brum, Cecilia H Gouveia, Double disruption of α2A- and α2C -adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype, Journal of Bone and Mineral Research, 2011, 26, 3
  18. 18
    Elisabet Ametller, Sílvia Busquets, Gemma Fuster, Maria T. Figueras, Cibely Cristine Fontes De Oliveira, Míriam Toledo, Katarzyna Korzeniewska, Josep M. Argilés, Francisco J. López-Soriano, Effects of formoterol on protein metabolism in myotubes during hyperthermia, Muscle & Nerve, 2011, 43, 2
  19. 19
    Shogo Sato, Ken Shirato, Kaoru Tachiyashiki, Kazuhiko Imaizumi, Muscle Plasticity andβ2-Adrenergic Receptors: Adaptive Responses ofβ2-Adrenergic Receptor Expression to Muscle Hypertrophy and Atrophy, Journal of Biomedicine and Biotechnology, 2011, 2011, 1

    CrossRef

  20. 20
    Guang-Liang Jiang, Yu-Dong Gu, Li-Yin Zhang, Li-Ying Shen, Cong Yu, Jian-Guang Xu, Randomized, Double-Blind, and Placebo-Controlled Trial of Clenbuterol in Denervated Muscle Atrophy, ISRN Pharmaceutics, 2011, 2011, 1

    CrossRef

  21. 21
    Míriam Toledo, Sílvia Busquets, Elisabet Ametller, Francisco J. López-Soriano, Josep M. Argilés, Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats: a role in impaired regeneration?, Journal of Cachexia, Sarcopenia and Muscle, 2011, 2, 1
  22. 22
    Shogo Sato, Ken Shirato, Kaoru Tachiyashiki, Kazuhiko Imaizumi, Synthesized glucocorticoid, dexamethasone regulates the expressions of β2-adrenoceptor and glucocorticoid receptor mRNAs but not proteins in slow-twitch soleus muscle of rats, The Journal of Toxicological Sciences, 2011, 36, 4, 479

    CrossRef

  23. 23
    Kyung Ho Kim, Yong Soo Kim, Jinzeng Yang, The muscle-hypertrophic effect of clenbuterol is additive to the hypertrophic effect of myostatin suppression, Muscle & Nerve, 2011, 43, 5
  24. 24
    Shogo Sato, Sachiko Nomura, Fuuun Kawano, Jun Tanihata, Kaoru Tachiyashiki, Kazuhiko Imaizumi, Adaptive effects of the β2-agonist clenbuterol on expression of β2-adrenoceptor mRNA in rat fast-twitch fiber-rich muscles, The Journal of Physiological Sciences, 2010, 60, 2, 119

    CrossRef

  25. 25
    Hye-Kyeong Kim, Mary Anne Della-Fera, Dorothy B. Hausman, Clifton A. Baile, Effect of clenbuterol on apoptosis, adipogenesis, and lipolysis in adipocytes, Journal of Physiology and Biochemistry, 2010, 66, 3, 197

    CrossRef

  26. You have free access to this content26
    James G Ryall, Jarrod E Church, Gordon S Lynch, Novel role for β-adrenergic signalling in skeletal muscle growth, development and regeneration, Clinical and Experimental Pharmacology and Physiology, 2010, 37, 3
  27. 27
    Ho Cheol Kim, Gi Dong Lee, Young Sil Hwang, Skeletal Muscle Dysfunction in Patients with Chronic Obstructive Pulmonary Disease, Tuberculosis and Respiratory Diseases, 2010, 68, 3, 125

    CrossRef

  28. 28
    A. C. Dilger, S. R. Gabriel, L. W. Kutzler, F. K. McKeith, J. Killefer, The myostatin null mutation and clenbuterol administration elicit additive effects in mice, animal, 2010, 4, 03, 466

    CrossRef

  29. 29
    A. Mittal, S. Bhatnagar, A. Kumar, E. Lach-Trifilieff, S. Wauters, H. Li, D. Y. Makonchuk, D. J. Glass, A. Kumar, The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice, The Journal of Cell Biology, 2010, 188, 6, 833

    CrossRef

  30. 30
    Marco Marzioni, Giammarco Fava, Domenico Alvaro, Gianfranco Alpini, Antonio Benedetti, Control of Cholangiocyte Adaptive Responses by Visceral Hormones and Neuropeptides, Clinical Reviews in Allergy & Immunology, 2009, 36, 1, 13

    CrossRef

  31. 31
    Toshiaki Yamazaki, Masami Yokogawa, Katsuhiko Tachino, Effects of Combined Stretching and Clenbuterol on Disuse Atrophy in Rat Soleus Muscle, Journal of the Japanese Physical Therapy Association, 2009, 12, 1, 13

    CrossRef

  32. 32
    Nan Liu, Pu Su, Zhixian Gao, Maoxiang Zhu, Zhihua Yang, Xiujie Pan, Yanjun Fang, Fuhuan Chao, Simultaneous detection for three kinds of veterinary drugs: Chloramphenicol, clenbuterol and 17-beta-estradiol by high-throughput suspension array technology, Analytica Chimica Acta, 2009, 632, 1, 128

    CrossRef

  33. 33
    Diane Downie, Margaret I. Delday, Charlotte A. Maltin, Alan A. Sneddon, Clenbuterol increases muscle fiber size and GATA-2 protein in rat skeletal muscle in utero, Molecular Reproduction and Development, 2008, 75, 5
  34. 34
    HARUHIKO MADARAME, MITSUO NEYA, EISUKE OCHI, KOICHI NAKAZATO, YOSHIAKI SATO, NAOKATA ISHII, Cross-Transfer Effects of Resistance Training with Blood Flow Restriction, Medicine & Science in Sports & Exercise, 2008, 40, 2, 258

    CrossRef

  35. 35
    P. Badino, R. Odore, S. Pagliasso, A. Schiavone, C. Girardi, G. Re, Steroid and β-adrenergic receptor modifications in target organs of broiler chickens fed with a diet containing β2-adrenergic agents, Food and Chemical Toxicology, 2008, 46, 6, 2239

    CrossRef

  36. 36
    James G. Ryall, Gordon S. Lynch, The potential and the pitfalls of β-adrenoceptor agonists for the management of skeletal muscle wasting, Pharmacology & Therapeutics, 2008, 120, 3, 219

    CrossRef

  37. 37
    Jatin G. Burniston, Lynn McLean, Robert J. Beynon, David F. Goldspink, Anabolic effects of a non-myotoxic dose of the β2-adrenergic receptor agonist clenbuterol on rat plantaris muscle, Muscle & Nerve, 2007, 35, 2
  38. 38
    Gordon S. Lynch, Jonathan D. Schertzer, James G. Ryall, Therapeutic approaches for muscle wasting disorders, Pharmacology & Therapeutics, 2007, 113, 3, 461

    CrossRef

  39. 39
    Amino Acids and Proteins for the Athlete, 2007,

    CrossRef

  40. 40
    Peter Molenaar, Lu Chen, William A Parsonage, Cardiac implications for the use of β2-adrenoceptor agonists for the management of muscle wasting, British Journal of Pharmacology, 2006, 147, 6
  41. 41
    Jatin G. Burniston, William A. Clark, Lip-Bun Tan, David F. Goldspink, Dose-dependent separation of the hypertrophic and myotoxic effects of the β2-adrenergic receptor agonist clenbuterol in rat striated muscles, Muscle & Nerve, 2006, 33, 5
  42. 42
    Satonari Akutsu, Akemi Shimada, Akira Yamane, Transforming growth factor βs are upregulated in the rat masseter muscle hypertrophied by clenbuterol, a β2 adrenergic agonist, British Journal of Pharmacology, 2006, 147, 4
  43. 43
    Ada H. Y. Yuen, Magdi H. Yacoub, Ryszard T. Smolenski, Determination of clenbuterol concentration in human blood using liquid chromatography with electrospray/ion-trap tandem mass spectrometry, Rapid Communications in Mass Spectrometry, 2005, 19, 23
  44. 44
    Jatin G. Burniston, Neil Chester, William A. Clark, Lip-Bun Tan, David F. Goldspink, Dose-dependent apoptotic and necrotic myocyte death induced by the β2-adrenergic receptor agonist, clenbuterol, Muscle & Nerve, 2005, 32, 6
  45. 45
    Toshiaki Yamazaki, Effects of Intermittent Weight-Bearing and Clenbuterol on Disuse Atrophy of Rat Hindlimb Muscles, Journal of the Japanese Physical Therapy Association, 2005, 8, 1, 9

    CrossRef

  46. 46
    Richard T. Hinkle, Elizabeth Dolan, David B. Cody, Mary Beth Bauer, Robert J. Isfort, Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy, Muscle & Nerve, 2005, 32, 6
  47. 47
    Clifford Pereira, Kevin Murphy, Marc Jeschke, David N. Herndon, Post burn muscle wasting and the effects of treatments, The International Journal of Biochemistry & Cell Biology, 2005, 37, 10, 1948

    CrossRef

  48. 48
    Maria Antonietta Pellegrino, Giuseppe D'Antona, Susan Bortolotto, Federica Boschi, Ornella Pastoris, Roberto Bottinelli, Biagio Polla, Carlo Reggiani, Clenbuterol antagonizes glucocorticoid-induced atrophy and fibre type transformation in mice, Experimental Physiology, 2004, 89, 1
  49. 49
    M. B. Lortie, T. Arnason, S. G. Dugan, J. G. Nickerson, T. W. Moon, The impact of feeding β2-adrenergic agonists on rainbow trout muscle β2-adrenoceptors and protein synthesis, Journal of Fish Biology, 2004, 65, 3
  50. 50
    Karen A Page, Diane L Hartzell, Changlong Li, Alisha L Westby, Mary Anne Della-Fera, Michael J Azain, T.Dean Pringle, Clifton A Baile, β-Adrenergic receptor agonists increase apoptosis of adipose tissue in mice, Domestic Animal Endocrinology, 2004, 26, 1, 23

    CrossRef